Background: Emerging evidence has revealed that genetic variations in microRNA (miRNA) binding sites called miRSNPs can alter miRNA binding in an allele-specific manner and impart prostate cancer (PCa) risk. Two miRSNPs, rs1530865 (G > C) and rs2357637 (C > A), in the 3′ untranslated region of pyruvate dehydrogenase kinase 1 (PDK1) have been previously reported to be associated with PCa risk. However, these results have not been functionally validated. Meth-ods: In silico analysis was used to predict miRNA–PDK1 interactions and was tested using PDK1 knockdown, miRNA overexpression and reporter gene assay. Results: PDK1 expression was found to be upregulated in PCa metastasis. Further, our results show that PDK1 suppression reduced the migra...
Background/Aims: MicroRNAs (miRNAs) are a class of small non-coding RNA molecules which play a signi...
Free to read Prostate cancer is the second most common malignancy among men worldwide. Genome-wide a...
AbstractMicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and met...
Background: Emerging evidence has revealed that genetic variations in microRNA (miRNA) binding sites...
Background: Emerging evidence has revealed that genetic variations in microRNA (miRNA) binding sites...
Objective: Pyruvate dehydrogenase kinase1 (PDK1), is a mitochondrial enzyme associated with metaboli...
Objective: Genome wide association studies (GWAS) recently identified single nucleotide polymorphism...
Background: Systematic approaches to functionally identify key players in microRNA (miRNA)-target ne...
Background: Recent evidence suggests that the prostate cancer (PCa)-specific up-regulation of certai...
PURPOSE: Serine peptidase inhibitor, Kazal type-1 (SPINK1) overexpression defines the second most re...
Purpose: Recent evidence indicates that small noncoding RNA molecules, known as microRNAs (miRNAs), ...
Accepted Preprint first posted online on 10 February 2015The oncogene MDM4, also known as MDMX or HD...
Dysregulation of miRNAs has been demonstrated in several human malignancies including prostate cance...
MiRNA-associated genetic variants occurring in regulatory regions can affect the efficiency of tra...
Prostate cancer (PCa) is the second most common cause of cancer-specific deaths in the U.S. Unfortun...
Background/Aims: MicroRNAs (miRNAs) are a class of small non-coding RNA molecules which play a signi...
Free to read Prostate cancer is the second most common malignancy among men worldwide. Genome-wide a...
AbstractMicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and met...
Background: Emerging evidence has revealed that genetic variations in microRNA (miRNA) binding sites...
Background: Emerging evidence has revealed that genetic variations in microRNA (miRNA) binding sites...
Objective: Pyruvate dehydrogenase kinase1 (PDK1), is a mitochondrial enzyme associated with metaboli...
Objective: Genome wide association studies (GWAS) recently identified single nucleotide polymorphism...
Background: Systematic approaches to functionally identify key players in microRNA (miRNA)-target ne...
Background: Recent evidence suggests that the prostate cancer (PCa)-specific up-regulation of certai...
PURPOSE: Serine peptidase inhibitor, Kazal type-1 (SPINK1) overexpression defines the second most re...
Purpose: Recent evidence indicates that small noncoding RNA molecules, known as microRNAs (miRNAs), ...
Accepted Preprint first posted online on 10 February 2015The oncogene MDM4, also known as MDMX or HD...
Dysregulation of miRNAs has been demonstrated in several human malignancies including prostate cance...
MiRNA-associated genetic variants occurring in regulatory regions can affect the efficiency of tra...
Prostate cancer (PCa) is the second most common cause of cancer-specific deaths in the U.S. Unfortun...
Background/Aims: MicroRNAs (miRNAs) are a class of small non-coding RNA molecules which play a signi...
Free to read Prostate cancer is the second most common malignancy among men worldwide. Genome-wide a...
AbstractMicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and met...